BBOT earnings: next report 2026-08-11, real EPS beat/miss history, analyst consensus Buy, P/E -1.56. Updated 2026-07-23.
BridgeBio Oncology Therapeutics (BBOT) Research Hub
BridgeBio Oncology Therapeutics (BBOT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 4.95 USD (-26.78%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.56, market cap 0.72B. This hub links to the full technical, earnings and options research available for BBOT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.95 USD (-26.78%) |
| 52-week range | 4.9 USD – 9.72 USD |
| Trend regime | Range |
| 14-day RSI | 16.9 (Oversold) |
| Trailing P/E | -1.56 |
| Market cap | 0.72B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for BBOT
Covered Call on BBOT: how it works, illustrative setup around the real 4.95 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BBOT: how it works, illustrative setup around the real 4.95 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BBOT: how it works, illustrative setup around the real 4.95 USD price, max profit/loss, breakeven and when to use it. Educational.
BBOT technical analysis: range, last 4.95 USD, RSI 16.9, 52w range 4.9 USD–9.72 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is BBOT in?
BridgeBio Oncology Therapeutics (BBOT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BBOT in an uptrend or downtrend?
As of 2026-09-11, BBOT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BBOT's trailing P/E ratio?
BBOT's trailing P/E is -1.56, with a market cap of 0.72B. See the earnings research page for full valuation detail.
When does BBOT next report earnings?
BBOT is next scheduled to report earnings on 2026-08-11, with a consensus EPS estimate of -0.54265 USD.